Effect of HMG-CoA Reductase Inhibitors on β-Amyloid Peptide Levels: Implications for Alzheimer's Disease

ISSN： 1172-7047

Source： CNS Drugs, Vol.21, Iss.6, 2007-01, pp. : 449-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of HMG-CoA Reductase Inhibitors on Coenzyme Q10: Possible Biochemical/Clinical Implications

By Hargreaves Iain P.

Drug Safety, Vol. 28, Iss. 8, 2005-01 ,pp. : 659-676

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 1, 2009-03 ,pp. : 1-26

Bentham Science Publishers

Access to resources Recommend Favorite

The effect of HMG-CoA reductase inhibitors on chronic allograft rejection

By Jones T.

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 1, 2001-04 ,pp. : 95-109

Informa Healthcare

Access to resources Recommend Favorite

The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function

By Tesfamariam Belay

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 115-120

Adis International

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors in the Prevention of Stroke

By van Mil A.H.M.

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite